The Risk of Transfusion-Transmitted Infection
Four key measures help keep the use of blood safe. First, all who prescribe blood should try to limit the frequency of homologous transfusion by responding only to patients' physiologic needs and by using alternatives such as autologous transfusion and intraoperative blood salvage. Second, the...
Gespeichert in:
| Veröffentlicht in: | The New England journal of medicine 1992-08, Vol.327 (6), p.419-421 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 421 |
|---|---|
| container_issue | 6 |
| container_start_page | 419 |
| container_title | The New England journal of medicine |
| container_volume | 327 |
| creator | Dodd, Roger Y |
| description | Four key measures help keep the use of blood safe. First, all who prescribe blood should try to limit the frequency of homologous transfusion by responding only to patients' physiologic needs and by using alternatives such as autologous transfusion and intraoperative blood salvage. Second, the selection of safe donors provides the greatest safety. For example, the current detection rate for human immunodeficiency virus (HIV) infection among active blood donors in the United States is between 5 and 10 confirmed positive results per 100,000 — that is, 1/40 to 1/80 of the rate anticipated in a random sample of the population, . . . |
| doi_str_mv | 10.1056/NEJM199208063270610 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73047307</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73047307</sourcerecordid><originalsourceid>FETCH-LOGICAL-c486t-4736f4156c18f06193f0970872c14f80ca205d1517b318fccb39d579f7418e3f3</originalsourceid><addsrcrecordid>eNp9kF1LwzAUhoMoc05_gQhFxRupnpOkSXMpY-pkKsi8Ll2aYGc_ZtNe-O_N7FAQNTcJOc857-Eh5BDhAiESlw-Tu3tUikIMglEJAmGLDDFiLOQcxDYZAtA45FKxXbLn3BL8Qa4GZICCRhLlkITzFxM85e41qG0wb9LK2c7ldRV-vsu8bU0WTCtrdOt_98mOTQtnDjb3iDxfT-bj23D2eDMdX81CzWPR-kQmLMdIaIytX0sxC0pCLKlGbmPQKYUowwjlgnlC6wVTWSSVlRxjwywbkbN-7qqp3zrj2qTMnTZFkVam7lwiGfgMkB48_gEu666p_G4JpUxxsVYzIid_Qahixj0VrSnWU7qpnWuMTVZNXqbNe4KQrH0nv_j2XUeb2d2iNNl3Ty_Y10839dTptLDeqs7dF8aZogq5x857rCxdUpll-W_oB4Mgj2Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1983446856</pqid></control><display><type>article</type><title>The Risk of Transfusion-Transmitted Infection</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>New England Journal of Medicine</source><creator>Dodd, Roger Y</creator><creatorcontrib>Dodd, Roger Y</creatorcontrib><description>Four key measures help keep the use of blood safe. First, all who prescribe blood should try to limit the frequency of homologous transfusion by responding only to patients' physiologic needs and by using alternatives such as autologous transfusion and intraoperative blood salvage. Second, the selection of safe donors provides the greatest safety. For example, the current detection rate for human immunodeficiency virus (HIV) infection among active blood donors in the United States is between 5 and 10 confirmed positive results per 100,000 — that is, 1/40 to 1/80 of the rate anticipated in a random sample of the population, . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJM199208063270610</identifier><identifier>PMID: 1625717</identifier><identifier>CODEN: NEJMAG</identifier><language>eng</language><publisher>Boston, MA: Massachusetts Medical Society</publisher><subject>Acquired immune deficiency syndrome ; AIDS ; AIDS/HIV ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Babesia microti ; Biological and medical sciences ; Blood & organ donations ; Blood Donors ; Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis ; Editorials ; Hepatitis C - prevention & control ; Hepatitis C - transmission ; HIV Infections - prevention & control ; HIV Infections - transmission ; Humans ; Medical sciences ; Transfusion Reaction ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy ; Trypanosoma cruzi ; Yersinia enterocolitica</subject><ispartof>The New England journal of medicine, 1992-08, Vol.327 (6), p.419-421</ispartof><rights>1993 INIST-CNRS</rights><rights>Copyright Massachusetts Medical Society Aug 6, 1992</rights><rights>Copyright Massachusetts Medical Society, Publishing Division Aug 6, 1992</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c486t-4736f4156c18f06193f0970872c14f80ca205d1517b318fccb39d579f7418e3f3</citedby><cites>FETCH-LOGICAL-c486t-4736f4156c18f06193f0970872c14f80ca205d1517b318fccb39d579f7418e3f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJM199208063270610$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJM199208063270610$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>314,776,780,2746,2747,26080,27901,27902,52357,54039</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4392914$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1625717$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dodd, Roger Y</creatorcontrib><title>The Risk of Transfusion-Transmitted Infection</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>Four key measures help keep the use of blood safe. First, all who prescribe blood should try to limit the frequency of homologous transfusion by responding only to patients' physiologic needs and by using alternatives such as autologous transfusion and intraoperative blood salvage. Second, the selection of safe donors provides the greatest safety. For example, the current detection rate for human immunodeficiency virus (HIV) infection among active blood donors in the United States is between 5 and 10 confirmed positive results per 100,000 — that is, 1/40 to 1/80 of the rate anticipated in a random sample of the population, . . .</description><subject>Acquired immune deficiency syndrome</subject><subject>AIDS</subject><subject>AIDS/HIV</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Babesia microti</subject><subject>Biological and medical sciences</subject><subject>Blood & organ donations</subject><subject>Blood Donors</subject><subject>Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis</subject><subject>Editorials</subject><subject>Hepatitis C - prevention & control</subject><subject>Hepatitis C - transmission</subject><subject>HIV Infections - prevention & control</subject><subject>HIV Infections - transmission</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Transfusion Reaction</subject><subject>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><subject>Trypanosoma cruzi</subject><subject>Yersinia enterocolitica</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kF1LwzAUhoMoc05_gQhFxRupnpOkSXMpY-pkKsi8Ll2aYGc_ZtNe-O_N7FAQNTcJOc857-Eh5BDhAiESlw-Tu3tUikIMglEJAmGLDDFiLOQcxDYZAtA45FKxXbLn3BL8Qa4GZICCRhLlkITzFxM85e41qG0wb9LK2c7ldRV-vsu8bU0WTCtrdOt_98mOTQtnDjb3iDxfT-bj23D2eDMdX81CzWPR-kQmLMdIaIytX0sxC0pCLKlGbmPQKYUowwjlgnlC6wVTWSSVlRxjwywbkbN-7qqp3zrj2qTMnTZFkVam7lwiGfgMkB48_gEu666p_G4JpUxxsVYzIid_Qahixj0VrSnWU7qpnWuMTVZNXqbNe4KQrH0nv_j2XUeb2d2iNNl3Ty_Y10839dTptLDeqs7dF8aZogq5x857rCxdUpll-W_oB4Mgj2Y</recordid><startdate>19920806</startdate><enddate>19920806</enddate><creator>Dodd, Roger Y</creator><general>Massachusetts Medical Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>19920806</creationdate><title>The Risk of Transfusion-Transmitted Infection</title><author>Dodd, Roger Y</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c486t-4736f4156c18f06193f0970872c14f80ca205d1517b318fccb39d579f7418e3f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>AIDS</topic><topic>AIDS/HIV</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Babesia microti</topic><topic>Biological and medical sciences</topic><topic>Blood & organ donations</topic><topic>Blood Donors</topic><topic>Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis</topic><topic>Editorials</topic><topic>Hepatitis C - prevention & control</topic><topic>Hepatitis C - transmission</topic><topic>HIV Infections - prevention & control</topic><topic>HIV Infections - transmission</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Transfusion Reaction</topic><topic>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</topic><topic>Trypanosoma cruzi</topic><topic>Yersinia enterocolitica</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dodd, Roger Y</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dodd, Roger Y</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Risk of Transfusion-Transmitted Infection</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>1992-08-06</date><risdate>1992</risdate><volume>327</volume><issue>6</issue><spage>419</spage><epage>421</epage><pages>419-421</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><coden>NEJMAG</coden><abstract>Four key measures help keep the use of blood safe. First, all who prescribe blood should try to limit the frequency of homologous transfusion by responding only to patients' physiologic needs and by using alternatives such as autologous transfusion and intraoperative blood salvage. Second, the selection of safe donors provides the greatest safety. For example, the current detection rate for human immunodeficiency virus (HIV) infection among active blood donors in the United States is between 5 and 10 confirmed positive results per 100,000 — that is, 1/40 to 1/80 of the rate anticipated in a random sample of the population, . . .</abstract><cop>Boston, MA</cop><pub>Massachusetts Medical Society</pub><pmid>1625717</pmid><doi>10.1056/NEJM199208063270610</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0028-4793 |
| ispartof | The New England journal of medicine, 1992-08, Vol.327 (6), p.419-421 |
| issn | 0028-4793 1533-4406 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_73047307 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; New England Journal of Medicine |
| subjects | Acquired immune deficiency syndrome AIDS AIDS/HIV Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Babesia microti Biological and medical sciences Blood & organ donations Blood Donors Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis Editorials Hepatitis C - prevention & control Hepatitis C - transmission HIV Infections - prevention & control HIV Infections - transmission Humans Medical sciences Transfusion Reaction Transfusions. Complications. Transfusion reactions. Cell and gene therapy Trypanosoma cruzi Yersinia enterocolitica |
| title | The Risk of Transfusion-Transmitted Infection |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T01%3A30%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Risk%20of%20Transfusion-Transmitted%20Infection&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Dodd,%20Roger%20Y&rft.date=1992-08-06&rft.volume=327&rft.issue=6&rft.spage=419&rft.epage=421&rft.pages=419-421&rft.issn=0028-4793&rft.eissn=1533-4406&rft.coden=NEJMAG&rft_id=info:doi/10.1056/NEJM199208063270610&rft_dat=%3Cproquest_cross%3E73047307%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1983446856&rft_id=info:pmid/1625717&rfr_iscdi=true |